Degayo, Jairah Dawn D.

HRN: 27-22-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2025
CEFUROXIME 1.5GM (VIAL)
09/22/2025
09/29/2025
IV
300mg
Q8H
Acute Respiratory Infection
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines